Clinical Trials in San Antonio

Showing 4981-5000 of 14,633 trials

Viz HCM (ECG Assist) Utilization Workflow Pilot

NCT06600256

This is a prospective, open-label, multi-center workflow pilot. Viz HCM will be implemented at each participating site and all conforming incoming ECG recordings within a 6-month enrollment period will be analyzed using Viz HCM. This workflow pilot provides an opportunity to understand how Viz HCM will be utilized and adopted post-market and to learn the pre- versus post-implementation impact of Viz HCM on HCM clinical workflow. This pilot is designed to evaluate the implementation of Viz HCM for use in traditional HCM clinical workflow. Findings from this pilot will help inform the following: * The impact of Viz HCM on HCM clinical workflow * How Viz HCM will be utilized and adopted post-market * The diversity in the HCM patient population and the variation in HCM clinical workflow

Hypertrophic Cardiomyopathy

Viz.ai, Inc.217 participantsStarted Jan 2022

La Jolla, California, United States • Ridgewood, New Jersey, United States • New York, New York, United States +2 more locations

COMPLETEDPhase 1< 1 mile

A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy Participants

NCT06211179

The purpose of this study to assess the relative bioavailability of 5 mg Mavacamten opened capsule administered via nasogastric tube compared to intact oral 5 mg Mavacamten in healthy volunteers.

Healthy Volunteers

Bristol-Myers Squibb34 participantsStarted Jan 2024

San Antonio, Texas, United States

Viz HCM (ECG Assist) Utilization Workflow Pilot

A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy Participants

Find Trials by Condition in San Antonio

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain

Breast Cancer Index (BCI) Registry

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Clinical Evaluation of the i-STAT TBI Test

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

A Safety and Efficacy Study in Patients With Gastric Cancer

Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer

Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

Acupuncture for Preterm Infants Requiring Eye-exam

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry